Journals / Turkish Journal of Medical Sciences / 2020 / Cilt: 50 - Sayı: 1

Patients with COPD who underwent pulmonary rehabilitation in Turkey: prevalence, distribution, and mortality

Pages
141–147
Publication Date
2020-01-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In order to achieve this, we think that PR should be within the scope of health policies.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background: Pulmonary rehabilitation PR is an effective, evidenced-based treatment.
📊
Key Findings & Data:The aim of this study was to present the number of patients with chronic obstructive pulmonary disease COPD who underwent PR, general mortality percentages, the rate of patients prescribed PR by pulmonologists, and the distribution of institutions where PR was performed between 2008 and 2016 in Turkey.
💡
Conclusion & Impact:In order to achieve this, we think that PR should be within the scope of health policies.
🔬Design:Research Article
📍Scope:2008 Verileri
⚙️Variables:Pulmonary rehabilitation · chronic obstructive pulmonary disease · pulmonologist

Abstract

Background: Pulmonary rehabilitation PR is an effective, evidenced-based treatment. Despite its proven effect, it is still underused. The aim of this study was to present the number of patients with chronic obstructive pulmonary disease COPD who underwent PR, general mortality percentages, the rate of patients prescribed PR by pulmonologists, and the distribution of institutions where PR was performed between 2008 and 2016 in Turkey. Materials and methods: The documents were obtained from Turkish Institution of Social Insurance. Ages, sexes, and numbers of patients with COPD who underwent PR between 2008 and 2016 were recorded. The number of patients with COPD who had been prescribed PR by physicians and the type of hospitals in which these patients underwent PR were identified. The general annual and the general total mortality rates between 2008 and 2016 among patients with COPD who underwent PR in 2008 were also determined.Results: The mean age ranges of patients with COPD who underwent PR were 67.4 ± 12.3 to 72.0 ± 13.2 years, and 62.2% n = 60,852 of patients were male. The number of patients increased progressively from 3,214 to 18,664. The rate of patients prescribed PR programs between 2008 and 2016 was between 0.32% and 0.59% among all registered patients with COPD. Between 52.0% and 94.8% 5,488/10,549 and 16,792/17,707 patients, respectively of the programs were prescribed by a pulmonologist, and 62.9% n = 62,613 of patients received PR in secondary public hospitals. The general annual mortality rates were between 6.2% and 11.1% 115/1,855 and 358/3,214 patients in patients who underwent PR in 2008, and the general total mortality rate was 52.8% 1,696/3,214 patients over the 9-year period in the same patient group.Conclusion: PR was still an underutilized approach in Turkey between 2008 and 2016. The awareness of PR should be increased in our country. In order to achieve this, we think that PR should be within the scope of health policies.

🔖

Cite This Article

ÖZDEMİR, T., CANDEMİR, İ., ERGÜN, P., TÜRKKANI, M. H., KOÇ, O. (2020). Patients with COPD who underwent pulmonary rehabilitation in Turkey: prevalence, distribution, and mortality. Turkish Journal of Medical Sciences, Cilt: 50 - Sayı: 1, 141–147. https://ajindex.com/articles/113281

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Vogelmeier CF, Criner GJ, Martinez FJ, Anzueto A, Barnes PJ et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD executive summary. American Journal of Respiratory and Critical Care Medicine 2017
  2. 195 (5): 557-582. doi: 10.1164/rccm.201701-0218PP 2. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012
  3. 380 (9859): 2095-2128. doi: 10.1016/S0140-6736(12)61728-0 3. McCarthy B, Casey D, Devane D, Murphy K, Murphy E et al. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Systematic Reviews 2015
  4. : CD003793. doi: 10.1002/14651858.CD003793.pub3 4. Milner SC, Boruff JT, Beaurepaire C, Ahmed S, JanaudisFerreira T. Rate of, and barriers and enablers to, pulmonary rehabilitation referral in COPD: a systematic scoping review. Respiratory Medicine 2018
  5. doi: 10.1016/j. rmed.2018.02.021 5. Kocabas A, Hancioglu A, Turkyilmaz S, Unalan T, Umut S et al. Prevalence of COPD in Adana, Turkey (BOLD-Turkey study). Proceedings of the American Thoracic Society 2006
  6. A543. 6. Gunen H, Hacievliyagil SS, Yetkin O, Gulbas G, Mutlu LC et al. Prevalence of COPD: First epidemiological study of a large region in Turkey. European Journal of Internal Medicine 2008
  7. 19 (7): 499-504. doi: 10.1016/j.ejim.2007.06.028 7. Deveci F, Deveci SE, Türkoğlu S, Turgur T, Kirkil G et al. The prevalence of chronic obstructive pulmonary disease in Elazığ, eastern Turkey. European Journal of Internal Medicine 2011
  8. 22 (2): 172-176. doi: 10.1016/j.ejim.2010.12.014 8. The Ministry of Health Turkey, Institute of Public Health. Chronic Diseases and Risk Factors Survey in Turkey. Ankara, Turkey: Ministry of Health
  9. Hakamy A, Bolton CE, McKeever TM. The effect of pulmonary rehabilitation on mortality, balance, and risk of fall in stable patients with chronic obstructive pulmonary disease. A systematic review. Chronic Respiratory Disease 2017
  10. 14 (1): 54-62. doi: 10.1177/1479972316661925 10. Camp PG, Hernandez P, Bourbeau J, Kirkham A, Debigare R et al. Pulmonary rehabilitation in Canada: a report from the Canadian Thoracic Society COPD Clinical Assembly. Canadian Respiratory Journal 2015
  11. 22 (3): 147-152. doi: 10.1155/2015/369851 11. McNaughton A, Weatherall M, Williams G, Delacey D, George C et al. An aud